1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
Summary
The industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -UAE”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UAE. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape, and healthcare infrastructure of the UAE. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.
The UAE healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The UAE’s pharmaceutical market value in terms of US dollars was $1.51B in 2011 and increased at a CAGR of 13.2% to $2.20B in 2014. The market value is expected to increase further to $6.74B by 2023. The UAE medical device market was valued at $0.68B in 2015, which increased to $0.80B in 2018.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UAE, and includes -
Reasons to buy
The report will enhance your decision-making capability by allowing you to -
Summary
The industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -UAE”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UAE. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape, and healthcare infrastructure of the UAE. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.
The UAE healthcare market is one of the major emerging markets in the world, with a strong focus on research and development (R&D). The UAE’s pharmaceutical market value in terms of US dollars was $1.51B in 2011 and increased at a CAGR of 13.2% to $2.20B in 2014. The market value is expected to increase further to $6.74B by 2023. The UAE medical device market was valued at $0.68B in 2015, which increased to $0.80B in 2018.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UAE, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, Roche, Sanofi, and Julphar) and profiles and SWOT analyses of the major players in the medical device market (Abbott, Medtronic, Philips Healthcare, GE Healthcare, and Siemens)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of UAE
- Porter’s five forces analysis for pharmaceutical and medical devices market of UAE
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the UAE healthcare market
Reasons to buy
The report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the UAE healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the UAE healthcare market
Note: Product cover images may vary from those shown
1 Executive Summary
2 Overview of Pharmaceutical Market
3 Overview of Medical Devices Market
4 Pharmaceutical and Medical Device Market - Drivers and Barriers
5 Deal Analysis
6 HealthTech Landscape
7 Pharmaceutical and Medical Device Market - Porter’s Five Forces Analysis
8 Market Access
9 Country Healthcare Landscape
List of Tables
List of Figures
Note: Product cover images may vary from those shown